Cargando…
New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial
AIM: To evaluate the efficacy and safety of HL tablet extracted from magnolia officinalis for treating patients with nonalcoholic fatty liver disease (NAFLD). METHODS: Seventy-four patients with NAFLD diagnosed by ultrasonography were randomly assigned to 3 groups given high dose (400 mg) HL tablet,...
Autores principales: | Jeong, Jae Yoon, Sohn, Joo Hyun, Baek, Yang Hyun, Cho, Yong Kyun, Kim, Yongsoo, Kim, Hyeonjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583583/ https://www.ncbi.nlm.nih.gov/pubmed/28932090 http://dx.doi.org/10.3748/wjg.v23.i32.5977 |
Ejemplares similares
-
Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial
por: Kim, So Jeong, et al.
Publicado: (2019) -
Randomized, double-blinded, placebo-controlled trial evaluating simethicone pretreatment with bowel preparation during colonoscopy
por: Rishi, Mohit, et al.
Publicado: (2019) -
Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS)
por: Boyer, Olivier, et al.
Publicado: (2018) -
Effect of probiotics on length of hospitalization in mild acute pancreatitis: A randomized, double-blind, placebo-controlled trial
por: Wan, You-Dong, et al.
Publicado: (2021) -
Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study
por: Turan, Beril, et al.
Publicado: (2021)